Royalty Pharma - Dividend History | RPRX
Historical dividend payout and yield for Royalty Pharma (RPRX) since 2022. The current TTM dividend payout for Royalty Pharma (RPRX) as of July 22, 2021 is $0.68. The current dividend yield for Royalty Pharma as of July 22, 2021 is 1.65%.
||Finance - Miscellaneous Services
Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.